Share Twitter LinkedIn Facebook Email Aaron Gerds, MD of @CleClinicMD discusses the phase 2 study of luspatercept in patients with myelofibrosis-associated anemia Advertisement
Spotlight on Myelofibrosis 2024: The Critical Evolution of JAK Inhibitors Myeloproliferative Disease 3 Mins Read
Warning: Undefined array key "file" in /home2/medicusn/public_html/.website_03b234a0/wp-content/themes/smart-mag/inc/media.php on line 688 Rusfertide: A New Horizon in Polycythemia Vera Treatment? Hematologic Malignancies 7 Mins Read